| View |
|
DR-XY48449
|
Risperidone
|
None
|
2 mg
|
Orodispersible Tablet
|
-
|
Kusum Healthcare Pvt. Ltd.
|
India
|
Initial
|
17 November 2022
|
17 November 2027
|
| View |
|
DRP-12972
|
Gefitinib
|
Gefticip
|
250 mg
|
Film-Coated Tablet
|
-
|
Cipla Limited (Unit X)
|
India
|
Initial
|
17 November 2022
|
17 November 2027
|
| View |
|
DR-XY48462
|
Glutathione
|
Sitiglow
|
600mg
|
Lyophilized Powder for Injection (IM/IV)
|
Antidote
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
Initial
|
14 November 2022
|
14 November 2027
|
| View |
|
DR-XY48461
|
Lornoxicam
|
Laxico
|
8 mg
|
Film-Coated Tablet
|
-
|
Kusum Healthcare Pvt. Ltd.
|
India
|
Initial
|
14 November 2022
|
14 November 2027
|
| View |
|
DR-XY48475
|
Gefitinib
|
Gefitero
|
250 mg
|
Film-Coated Tablet
|
-
|
Hetero Labs Limited (Unit-V, Block-VB)
|
India
|
Initial
|
18 November 2022
|
18 November 2027
|
| View |
|
DR-XY48471
|
Dolutegravir (as sodium) + Lamivudine + Tenofovir
Disoproxil Fumarate
|
None
|
50mg/300mg/300mg
|
Film-Coated Tablet
|
Antiviral Combination
|
Sun Pharmaceutical Industries Limited
|
India
|
Monitored Release (Reconstruction)
|
12 August 2024
|
17 November 2027
|
| View |
|
DRP-12989
|
Metformin Hydrochloride
|
None
|
1 g
|
Film-Coated Tablet
|
-
|
United International Pharma Co. Ltd.
|
Vietnam
|
Initial
|
16 November 2022
|
16 November 2027
|
| View |
|
DR-XY48427
|
Cefuroxime (as sodium)
|
Eoroxime-750
|
750 mg
|
Powder for Injection (IM/IV)
|
-
|
Zee Laboratories Limited
|
India
|
Initial
|
16 November 2022
|
16 November 2027
|
| View |
|
DRP-1554-06
|
Metoprolol Tartrate
|
Betrol
|
100 mg
|
Film-Coated Tablet
|
Beta-Adrenoceptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 February 2024
|
30 March 2029
|
| View |
DRP-3602-04_PI_01.pdf
|
DRP-3602-04
|
Thiamine mononitrate (Vitamin B1) + Pyridoxine hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
300mg/100 mg/100 mcg
|
Capsule
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
28 November 2022
|
26 May 2026
|
| View |
|
DRP-5723-12
|
Dobutamine (as Hydrochloride)
|
Dobukon
|
50 mg/mL (250 mg/ 5 mL )
|
Solution for Injection (IV Infusion)
|
Adrenergic Agent
|
Myungmoon Pharmaceutical Co., Ltd
|
Korea
|
Renewal
|
30 May 2023
|
18 July 2028
|
| View |
|
DRP-5768-01
|
Losartan Potassium
|
Malsar
|
50 mg
|
Tablet
|
Angiotensin-2-Receptor Blocker
|
PharmEvo (Pvt.) Ltd
|
Pakistan
|
Renewal
|
28 November 2022
|
04 December 2028
|
| View |
|
DRP-6042-01
|
Clopidogrel (as Bisulfate)
|
Shegrel
|
75 mg
|
Film-Coated Tablet
|
-
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
28 November 2022
|
13 March 2025
|
| View |
|
DRP-6149-01
|
Amlodipine (As Besilate)
|
Malapine-10
|
10 mg
|
Tablet
|
-
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
28 November 2022
|
11 May 2025
|
| View |
|
DRP-8863-01
|
Multivitamins + Dextrose
|
Goprime IV
|
|
Solution for IV Infusion
|
-
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
28 November 2022
|
06 July 2025
|
| View |
|
DRP-9114-02
|
Carboplatin
|
Carbofree
|
10mg/mL (450mg/45mL)
|
Solution for Intravenous Infusion
|
-
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
28 November 2022
|
06 October 2025
|
| View |
|
DRP-9299-02
|
Ascorbic Acid + Zinc
|
None
|
533.40 mg (equivalent to 600 mg Sodium ascorbate) / 10 mg (equivalent to 27.45 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Interchemex Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
28 November 2022
|
17 November 2025
|
| View |
|
DRP-9726-01
|
Valganciclovir (as hydrochloride)
|
Valgancyte
|
450 mg
|
Film-Coated Tablet
|
Direct Acting Antiviral
|
Pharose Remedies Ltd.
|
India
|
Renewal
|
19 April 2024
|
09 February 2028
|
| View |
|
DRP-10530-02
|
Linezolid
|
Gozolide
|
2mg/mL (600mg/300mL)
|
Solution for Injection for I.V Infusion
|
-
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
28 November 2022
|
12 October 2026
|
| View |
|
DRP-10710-02
|
Piperacillin (As Sodium) + Tazobactam (As Sodium)
|
Gotazo IV
|
4g/500mg
|
Powder for Injection (IV)
|
-
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
CLIDP Conversion
|
28 November 2022
|
01 December 2026
|